Status | Study |
Recruiting |
Study Name: Timing of Initiation of LMWH Administration in Pregnant Women With APS Condition: Recurrent Miscarriage Antiphospholipid Syndrome Date: 2014-12-22 Interventions: Drug: Enoxaparin Women will st |
Recruiting |
Study Name: Use of Warfarin After the First Trimester in Pregnant Women With APS Condition: Recurrent Miscarriage Antiphospholipid Syndrome Date: 2014-11-25 Interventions: Drug: Enoxaparin Women will be |
Recruiting |
Study Name: Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome Condition: Antiphospholipid Syndrome Thrombosis Date: 2014-11-18 Interventions: Drug: Apixaban Study subjects |
Recruiting |
Study Name: Rivaroxaban in Thrombotic Antiphospholipid Syndrome Condition: Antiphospholipid Syndrome Date: 2014-05-31 Interventions: Drug: Experimental: Rivaroxaban The investigated drug is Rivaroxaban 20mg, a film coated tablet, which i |
Completed |
Study Name: CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients Condition: Antiphospholipid Antibody Syndrome Date: 2014-05-13 Interventions: Device: CoaguChek XS CoaguChek |
Completed |
Study Name: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome Condition: Antiphospholipid (aPL)-Positive Date: 2014-04-29 Interventions: Biological: Study Drug- ALXN1007 10 mg/kg IV q 2 weeks x 12 doses |
Recruiting |
Study Name: Rivaroxaban for Antiphospholipid Antibody Syndrome Condition: Antiphospholipid Antibody Syndrome Date: 2014-04-14 Interventions: Drug: Rivaroxaban Other Name: Xarelto |
Recruiting |
Study Name: The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome Condition: Antiphospholipid Syndrome Endothelial Dysfunction Date: 2013-03-21 |
Active, not recruiting |
Study Name: Pilot Study of Gut Commensals in Antiphospholipid Syndrome Condition: Antiphospholipid Syndrome (APS) Date: 2013-02-03 |
Terminated |
Study Name: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients Condition: Antiphospholipid Syndrome Date: 2013-02-03 Interventions: Drug: Hydroxychloroquine Other Name: plaquenil |